Filing Details

Accession Number:
0001654954-24-007748
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-13 18:32:05
Reporting Period:
2024-06-12
Accepted Time:
2024-06-13 18:32:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1684144 Zomedica Corp. ZOM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1999774 Kevin Russell Klass C/O Zomedica Corp.
100 Phoenix Drive, Suite 125
Ann Arbor MI 48108
Vice President Of Sales No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Without Par Value Acquisiton 2024-06-12 299,993 $0.16 2,000,050 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is the weighted average price. These shares were sold in multiple transactions ranging from $0.1520 to $0.1559, inclusive. The reporting person undertakes to provide to Zomedica Corp., any security holder of Zomedica Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the preceding sentence.